Tratamiento de la anovulación crónica | 28 NOV 01

Como optimizar el tratamiento de la anovulación crónica con citrato de clomifeno

En este artículo se plantean distintas situaciones por las cuales puede no haber una buena respuesta al tratamiento.
Autor: Dres. Robert L. Barbieri y Mark D. Hornstein. 
1. Adashi EY. Clomiphene citrate-initiated ovulation. Semin Reprod Endocrinol. 1986;4:255.

2. Bates GW, Bates SR, Whitworth NS. Reproductive failure in women who practice weight control. Fertil Steril. 1982;37:373-378.

3. Murakawa H, Hasegawa I, Kurabayashi T, et al. Polycystic ovary syndrome: insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med. 1999;44:23-27.

4. Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese and amenorrheic women before and after weight loss. J Clin Endocrinol Metab. 1989;68:173-179.

5. Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese infertile women. Fertil Steril. 1982;38:406-409.

6. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic anovulatory women. Fertil Steril. 1994;61:598-604.

7. Huber-Buchholz MM, Carey DGP, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470-1474.

8. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62:904-910.

9. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876-1880.

10. Morin-Papunen LC, Koivunen RM, Ruokonen A, Martikainen HK. Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome. Fertil Steril. 1998;69:691-696.

11. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab. 2000;85:139-146.

12. Sarlis NJ, Weil SJ, Nelson LM. Administration of metformin to a diabetic woman with extreme hyperandrogenemia of non-tumoral origin, management of infertility and prevention of inadvertent masculinization of a female fetus. J Clin Endocrinol Metab. 1999;84:1510-1512.

13. Coetzee EJ, Jackson WP. The management of non-insulin dependent diabetes during pregnancy. Diabetes Res Clin Pract. 1986;1:281-287.

14. Barbieri RL. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. Am J Obstet Gynecol. 2000;183:1412-1418.

15. Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147:90-101.

16. Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first trimester spontaneous abortion: a pilot study. Fertil Steril. 2001;75:46-52.

17. Daly DC, Walters CA, Soto-Albors CE, et al. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril. 1984;41:844-848.

18. Branigan EF, Estes MA. Treatment of chronic anovulation resistant to clomiphene citrate by using oral contraceptive ovarian suppression followed by repeat clomiphene treatment. Fertil Steril. 1999;71:544-546.


Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2017